Related Experiment Video
Updated: Feb 3, 2026

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
Survival Outcomes of Oversized Cardiac Allografts in Pediatric Patients-A Single-Center Experience in Taiwan
1Department of Surgery, National Taiwan University Hospital, and National Taiwan University College of Medicine, Taipei, Taiwan.
Insights
Oversized cardiac allografts in pediatric heart transplant recipients did not negatively impact survival outcomes. This study found no significant difference in short-term or long-term survival for children receiving larger donor hearts.
Area of Science:
- Cardiology
- Pediatric Surgery
- Transplantation Immunology
Background:
- The shortage of pediatric donor hearts often necessitates the use of oversized cardiac allografts.
- Previous studies suggested potential negative impacts of oversized allografts on survival outcomes.
Purpose of the Study:
- To evaluate the survival outcomes of pediatric patients undergoing cardiac transplantation in relation to the donor-recipient weight ratio.
- To determine if oversized cardiac allografts affect short-term and long-term survival in children.
Main Methods:
- A retrospective analysis of 28 children (3 months to 17 years) with dilated cardiomyopathy who underwent primary cardiac transplantation.
- Patients were categorized into two groups based on donor-recipient weight ratio: <2.5 (n=19) and ≥2.5 (n=9).
Main Results:
- Both groups demonstrated 100% 30-day survival.
- 1-year survival was 95% vs 100%, 5-year survival was 84% vs 89%, and 10-year survival was 73% vs 61% for the respective groups.
- Median survival was 14.4 years for the group with a ratio <2.5 and 12.9 years for the group with a ratio ≥2.5 (P=.6313).
Conclusions:
- The use of oversized cardiac allografts in pediatric patients with dilated cardiomyopathy did not adversely affect short-term or long-term survival in this cohort.
- These findings suggest that oversized allografts can be safely utilized when donor heart availability is limited.
Objectives:
An oversized cardiac allograft may have a negative impact on survival outcomes according to previous studies; however, due to the shortage of pediatric donor hearts, the use of oversized cardiac allografts is sometimes inevitable. In this study, we reported the survival outcomes of pediatric patients in relation with the donor-recipient weight ratio.
Methods:
Twenty-eight children, aged 3 months to 17 years, with dilated cardiomyopathy underwent primary cardiac transplantation at the National Taiwan University Hospital between 1995 and 2012. We analyzed these patients according to the donor-recipient weight ratio: group 1 (n = 19) with donor-recipient weight ratio <2.5 (median 1.1, interquartile range 1.0-1.6), and group 2 (n = 9) with donor-recipient weight ratio ≥2.5 (median 3.0, inter-quartile range 2.87-3.5).
Results:
The 30-day survival rate was 100% for both group 1 and group 2 (P = 1). The survival rates for group 1 and group 2 were 95% vs 100% at 1 year, 84% vs 89% at 5 years, and 73% vs 61% at 10 years. The median survival was 14.4 years vs 12.9 years (P = .6313).
Conclusion:
In this cohort, the use of oversized cardiac allograft in pediatric patients for dilated cardiomyopathy did not have a negative effect on short-term and long-term survival.
Related Concept Videos
Patient-centered Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...

